World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
49
Citations
9696
World Ranking
2627
National Ranking
1284

Overview

Humam Kadara is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant contributions in oncology, molecular biology, and pulmonary and respiratory medicine. The scientist has published extensively in fields related to cancer research and immunology.

Key topics in their work include:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Single-cell and Spatial Transcriptomics
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • Ferroptosis and Cancer Prognosis

Among their frequent co-authors are Ignacio I. Wistuba, Ansam Sinjab, Linghua Wang, Junya Fujimoto, and Tina Cascone, with collaboration counts ranging from 40 to 53 publications each.

Kadara has published numerous papers, including:

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, Nature Medicine
  • Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance, 2023, Nature Medicine
  • Comprehensive T cell repertoire characterization of non-small cell lung cancer, 2020, Nature Communications
  • Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities, 2020, Cancers
  • 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy, 2021, Nature Communications

The scientist has been published frequently in leading research venues, including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Regular and Young Investigator Award Abstracts
  • Cancer Discovery

Best Publications

  • Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

    Ferdinandos Skoulidis;Lauren A. Byers;Lixia Diao;Vassiliki A. Papadimitrakopoulou

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

    Orit Rozenblatt-Rosen;Aviv Regev;Aviv Regev;Aviv Regev;Philipp Oberdoerffer;Tal Nawy

  • Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells

    Ashutosh K. Pathak;Manisha Bhutani;Asha S. Nair;Kwang Seok Ahn

  • Comprehensive T cell repertoire characterization of non-small cell lung cancer

    Alexandre Reuben;Jiexin Zhang;Shin Heng Chiou;Rachel M. Gittelman

  • IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer

    Mauricio S. Caetano;Huiyuan Zhang;Amber M. Cumpian;Lei Gong

  • Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

    H. Kadara;Murim Choi;Murim Choi;J. Zhang;E. R. Parra

  • ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer

    Mohamed Kabbout;Melinda M. Garcia;Junya Fujimoto;Diane D. Liu

  • Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma

    Tina Cascone;Matthew H. Herynk;Li Xu;Zhiqiang Du

  • EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma

    Carmen Behrens;Luisa M. Solis;Heather Lin;Ping Yuan

  • Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities.

    Zeina Habli;Walid AlChamaa;Raya Saab;Humam Kadara

  • Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

    Edwin R Parra;Carmen Behrens;Jaime Rodriguez-Canales;Heather Y Lin

  • High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation

    Maria Ines Nunez;Carmen Behrens;Denise M. Woods;Heather Lin

  • Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

    Y. Kudo;Y. Kudo;C. Haymaker;J. Zhang;A. Reuben

  • Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung

    Ping Yuan;Humam Kadara;Carmen Behrens;Ximing Tang

  • 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.

    Guangchun Han;Guoliang Yang;Dapeng Hao;Yang Lu

  • Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome

    Luisa M. Solis;Carmen Behrens;M. Gabriela Raso;Heather Y. Lin

  • Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.

    Xin Hu;Junya Fujimoto;Lisha Ying;Junya Fukuoka

  • Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis

    Jiong Deng;Junya Fujimoto;Xiao Feng Ye;Tao Yan Men

  • Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

    Smruthy Sivakumar;F. Anthony San Lucas;Tina L. McDowell;Wenhua Lang

Frequent Co-Authors

Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Carmen Behrens
Carmen Behrens The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Paul Scheet
Paul Scheet The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Don L. Gibbons
Don L. Gibbons The University of Texas MD Anderson Cancer Center
Cesar A. Moran
Cesar A. Moran The University of Texas MD Anderson Cancer Center
Avrum Spira
Avrum Spira Boston University
Jing Wang
Jing Wang The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future beyond molecular biology? Advancements in online education have opened diverse career pathways in related fields such as psychology, counseling, human services, and speech pathology.

If you are interested in supporting others’ mental health, exploring online master degree programs in counseling could be a great next step. For those passionate about research and therapy, clinical psychology online degree options prepare students for clinical and research roles in healthcare or academia.

Careers in social support and advocacy are also accessible via online human services degree programs, which typically offer flexible and accelerated study formats. Additionally, if you’re considering roles like speech-language pathology, it is possible to build on prior education—discover how can you become a speech pathologist with an education degree.

These accessible online degrees can open numerous doors in healthcare, research, and public service, making them valuable complements or alternatives to a background in molecular biology.

Best Scientists Citing Humam Kadara

Trending Scientists